Altered gene expression in the eye of a mouse model for Batten disease

Investigative Ophthalmology and Visual Science

Volumn 45, Issue 9, 2004, Pages 2893-2905

  Chattopadhyay, Subrata ^a   Kingsley, Evan ^a   Serour, Andrew ^a   Curran, Timothy M ^a   Brooks, Andrew I ^b   Pearce, David A ^a,b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOFLUORESCENCE; AUTOSOMAL RECESSIVE INHERITANCE; CEREBELLUM; CLN3 GENE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DNA MICROARRAY; ENERGY YIELD; GENE; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; KNOCKOUT MOUSE; LYSOSOME STORAGE DISEASE; MENTAL DEFICIENCY; MITOCHONDRIAL RESPIRATION; MOTOR DYSFUNCTION; MOUSE; NEURONAL CEROID LIPOFUSCINOSIS; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEIZURE; VISUAL IMPAIRMENT;

ANIMALS; CEREBELLUM; DISEASE MODELS, ANIMAL; EYE; FLUORESCENCE; GENE EXPRESSION; GENE EXPRESSION PROFILING; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; MOLECULAR CHAPERONES; NEURONAL CEROID-LIPOFUSCINOSES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 4344670396     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.04-0143     Document Type: Article

References (21)

1. Goebel, HH, Mole SE, Lake BD, eds. The neuronal ceroid lipofuscinoses (Batten disease). Biomedical and Health Research. Amsterdam: IOS Press: 1999:211.
2. Wisniewski KE, Zhong N. Batten Disease: diagnosis, treatment, and research. In: Hall JC, ed. Advances in Genetics. San Diego: Academic Press; 2001:1-34.
3. International Batten Disease Consortium. Isolation of a novel gene underlying Batten disease. Cell 1995;82:949-957.
4. Palmer DN, Fearnley IM, Walker JE, et al. Mitochondrial ATP synthase subunit c storage in the ceroid-lipofuscinoses (Batten disease). Am J Med Genet. 1992;42:561-567.
5. Palmer DN, Bayliss SL, Westlake VJ. Batten disease and the ATP synthase subunit c turnover pathway: raising antibodies to subunit c. Am J Med Genet. 1995;57:260-265.
6. Kominami E, Ezaki J, Muno D, Ishido K, Ueno T, Wolfe LS. Specific storage of subunit c of mitochondrial ATP synthase in lysosomes of neuronal ceroid lipofuscinosis (Batten's disease). J Biochem. 1992;111:278-282.
7. Ezaki J, Wolfe LS, Higuit T, Ishidoh K, Kominami E. Specific delay of degradation of mitochondrial ATP synthase subunit c in late infantile neuronal ceroid lipofuscinosis (Batten disease). J Neurochem. 1995;64:733-741.
8. Jarvela I, Sainio M, Rantamaki T, et al. Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease. Hum Mol Genet. 1998;7:85-90.
9. Jarvela I, Lehtovirta M, Tikknen R, Kyttala A, Jalenko A. Defective intracellular transport of CLN3 is the molecular basis of Batten disease (JNCL). Hum Mol Genet. 1999;8:1091-1098.
10. Haskell RE, Carr CJ, Pearce DA, Bennett MJ, Davidson BL. Batten Disease: evaluation of CLN3 mutations on protein localization and function. Hum Mol Genet. 2000;9:735-744.
11. Mitchison HM, et al. Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. Neurobiol Dis. 1999;6:321-334.
12. Chattopadhyay S, Ito M, Cooper JD, Brooks AI, Curran TM, Pearce DA. An autoantibody inhibitory to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease. Hum Mol Genet. 2002;11:1421-1431.
13. Brooks AI, Chattopadhyay S, Mitchison HM, Nussbaum RL, Pearce DA. Functional categorization of gene expression changes in the cerebellum of a Cln3-knockout mouse model for Batten Disease. Mol Gen Metab. 2003;78:17-30.
14. Katz ML, Shibuya H, Liu P-C, Kaur S, Gao C-L, Johnson, GS. A mouse gene knockout model for juvenile ceroid-lipofuscinoses (Batten Disease). J Neurosci Res. 1999;57:551-556.
15. Seigel GM, Lotery A, Kummer A, et al. Retinal pathology and function in a Cln3 knockout mouse model of juvenile neuronal ceroid lipofuscinoses (Batten disease). Mol Cell Neurosci. 2002;19:515-527.
16. Mole SE. Batten Disease: Four genes and still counting. Neurobiol Dis. 1998;5:287-303.
17. Jolly RD, Brown S, Das AM, Walkely, SU. Mitochondrial dysfunction in the neuronal ceroid lipofuscinoses (batten disease). Neurochem Int. 2002;40:565-571.
18. Das AM, Kohlschutter A. Decreased activity of mitochondrial ATP synthase in fibroblasts from children with late infantile and juvenile neuronal ceroid-lipofuscinoses. J Inherit Metab Dis. 1996;19:137-139.
19. Das AM, Jolly RD, Kohlschutter A. Anomalies of mitochondrial ATP synthase regulation in four different forms of neuronal ceroid lipofuscinoses. Mol Genet Metab. 1999;66:349-355.
20. Dawson G, Kilrus J, Siakotos AN, Singh I. Mitochondrial abnormalities in CLN2 and CLN3 forms of batten disease. Mol Chem Neuropathol. 1996;29:227-235.
21. Siakotos AN, Blair PS, Savill JD, Katz ML. Altered mitochondrial function in canine ceroid lipofuscinoses. Neurochem Res. 1998;23:983-989.